Polyclonal Antibodies
Anti-CDKN1B/p27KIP1 Polyclonal Antibody for WB, IF/ICC, IHC-P, ELISA - P46527
Item Number : CM0017717
Price varies based on specs and customizations
- Application
- WB, IF/ICC, IHC-P, ELISA
- Cross Reactivity
- Human, Mouse, Rat
- Protein Weight
- 22kDa
Shipping:
Contact us to get shipping details Enjoy On-time Dispatch Guarantee.
Why Choose Us
Easy ordering process, quality products, and dedicated support for your business success.
Core Product Specifications and Parameters
| Parameter | Value |
|---|---|
| Product Name | CDKN1B/p27KIP1 Rabbit pAb |
| Remarks/Alias | KIP1; MEN4; CDKN4; MEN1B; P27KIP1; CDKN1B/p27KIP1 |
| Species | Human |
| GeneID (Human) | 1027 |
| GeneID | 1027 |
| Immunogen | Recombinant protein|Recombinant fusion protein containing a sequence corresponding to amino acids 1-198 of human CDKN1B/p27KIP1 (NP_004055.1). |
| Source | Rabbit |
| Category | Polyclonal Antibodies |
| Application | WB, IF/ICC, IHC-P, ELISA |
| Cross Reactivity | Human, Mouse, Rat |
| SWISS | P46527 |
| Protein Weight | 22kDa |
| Shipping | Ice bag |
Biological Background: CDKN1B/p27KIP1 Function and Localization
- CDKN1B encodes cyclin-dependent kinase inhibitor 1B, also known as p27Kip1, a key regulator of cell cycle progression, primarily mediating G1 arrest.
- It inhibits cyclin E-CDK2 and cyclin A-CDK2 complexes, thereby blocking cell cycle progression, but has little inhibitory effect on CDK2 bound to SPDYA. Related references: PMID:28666995
- p27Kip1 also interacts with cyclin D-CDK4 complexes, modulating their assembly, stability, and activation; its effect can be either inhibitory or activating depending on phosphorylation state and stoichiometry.
- Subcellular localization includes nucleus, cytoplasm, and endosomes, reflecting dynamic regulation during the cell cycle.
- Post-translational modifications, particularly phosphorylation, control p27Kip1 activity and subcellular distribution (Keywords: Phosphoprotein).
- It is expressed in all tissues tested, with highest levels in skeletal muscle and lowest in liver and kidney; protein expression confirmed in kidney. Related references: PMID:15509543 PMID:8033212
- Functionally, CDKN1B acts as a tumor suppressor, and its dysregulation is implicated in multiple cancers (Keywords: Tumor suppressor).
- The protein undergoes ubiquitin-like (Ubl) conjugation and is identified by proteomics, indicating post-translational control mechanisms.
Experimental Guidance and Technical Tips
- The immunogen spans the full-length human p27Kip1 (amino acids 1-198), encompassing known functional domains; the antibody may detect both phosphorylated and unphosphorylated forms — consider phosphatase treatment in relevant assays.
- For Western blotting, a band at approximately 22 kDa is expected; optimize antibody concentration and blocking conditions for your specific sample.
- In immunostaining (IF/ICC, IHC-P), note that p27Kip1 can localize to the nucleus, cytoplasm, or endosomes depending on cell cycle stage and modifications; validate subcellular distribution in your model system.
- As the antibody cross-reacts with mouse and rat, it is suitable for rodent studies; however, verify species-specific reactivity and background in your experimental setup.
- For ELISA, ensure appropriate coating and detection conditions; this antibody can be used for direct or indirect detection applications.
CamelBio: Your One-Stop Sourcing Bridge
CamelBio serves as a comprehensive sourcing bridge for IVD raw materials, connecting diagnostic manufacturers and research labs with high-quality reagents. For cell cycle and oncology research, we offer validated antibody pairs, optimized polyclonals like this anti-CDKN1B/p27KIP1 antibody, and bulk ancillary reagents to support assay development. If you're exploring rare or challenging targets, our sourcing network can help secure customized immunoreagents for your pipeline.
REQUEST A QUOTE
Our professional team will reply to you within one business day. Please feel free to contact us!